Page last updated: 2024-09-03

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and Hypertension, Pulmonary

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with Hypertension, Pulmonary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, JW; Smallbone, BW; Taylor, NE1
Imai, T; Jacob, HS; Moldow, CF; Vercellotti, GM; Weir, EK1

Other Studies

2 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and Hypertension, Pulmonary

ArticleYear
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:3

    Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan

1987
Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    The Journal of laboratory and clinical medicine, 1988, Volume: 111, Issue:2

    Topics: Animals; Diterpenes; Edema; Furans; Ginkgolides; Hypertension, Pulmonary; Injections, Intra-Arterial; Lactones; Lung; Male; Organ Size; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains

1988